Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Pharmacokinetic and pharmacodynamic properties of a new long-acting granulocyte colony-stimulating factor (HM10460A) in healthy volunteers.

Shin KH, Kim TE, Lim KS, Yoon SH, Cho JY, Kim SE, Park KM, Shin SG, Jang IJ, Yu KS.

BioDrugs. 2013 Apr;27(2):149-58. doi: 10.1007/s40259-013-0010-0.

PMID:
23359067
[PubMed - indexed for MEDLINE]
2.

Relationship between absolute neutrophil count profiles and pharmacokinetics of DA-3031, a pegylated granulocyte colony-stimulating factor (pegylated-G-CSF): a dose block-randomized, double-blind, dose-escalation study in healthy subjects.

Ahn LY, Shin KH, Lim KS, Kim TE, Jeon H, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS.

Clin Drug Investig. 2013 Nov;33(11):817-24.

PMID:
24078278
[PubMed - indexed for MEDLINE]
3.

Pharmacokinetic and pharmacodynamic profile of new biosimilar filgrastim XM02 equivalent to marketed filgrastim Neupogen: single-blind, randomized, crossover trial.

Lubenau H, Bias P, Maly AK, Siegler KE, Mehltretter K.

BioDrugs. 2009;23(1):43-51. doi: 10.2165/00063030-200923010-00005.

PMID:
19344191
[PubMed - indexed for MEDLINE]
4.

Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.

Akizuki S, Mizorogi F, Inoue T, Sudo K, Ohnishi A.

Bone Marrow Transplant. 2000 Nov;26(9):939-46.

PMID:
11100272
[PubMed - indexed for MEDLINE]
Free Article
5.

Bioequivalence of two recombinant granulocyte colony-stimulating factor formulations in healthy male volunteers.

Hernández-Bernal F, García-García I, González-Delgado CA, Valenzuela-Silva C, Soto-Hernández R, Ducongé J, Cervantes-Llano M, Blanco-Garcés E, Rodríguez V, García-Vega Y, Bello-Rivero I, Olivera-Ruano L, López-Saura P.

Biopharm Drug Dispos. 2005 May;26(4):151-9.

PMID:
15799006
[PubMed - indexed for MEDLINE]
6.

Effect of escalating doses of recombinant human granulocyte colony-stimulating factor (filgrastim) on circulating neutrophils in healthy subjects.

Borleffs JC, Bosschaert M, Vrehen HM, Schneider MM, van Strijp J, Small MK, Borkett KM.

Clin Ther. 1998 Jul-Aug;20(4):722-36.

PMID:
9737832
[PubMed - indexed for MEDLINE]
7.

Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.

van Der Auwera P, Platzer E, Xu ZX, Schulz R, Feugeas O, Capdeville R, Edwards DJ.

Am J Hematol. 2001 Apr;66(4):245-51.

PMID:
11279634
[PubMed - indexed for MEDLINE]
8.

Pharmacokinetics of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) in healthy male volunteers.

Houston AC, Stevens LA, Cour V.

Br J Clin Pharmacol. 1999 Mar;47(3):279-84.

PMID:
10215752
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Bioequivalence of two recombinant granulocyte colony-stimulating factor products after subcutaneous injection in healthy volunteers.

Lubenau H, Sveikata A, Gumbrevicius G, Macijauskiene J, Fokas V, Kazlauskas S, Janulionis V.

Int J Clin Pharmacol Ther. 2009 Apr;47(4):275-82.

PMID:
19356394
[PubMed - indexed for MEDLINE]
10.

Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.

Sarashina A, Sesoko S, Nakashima M, Hayashi N, Taniguchi A, Horie Y, Graefe-Mody EU, Woerle HJ, Dugi KA.

Clin Ther. 2010 Jun;32(6):1188-204. doi: 10.1016/j.clinthera.2010.06.004.

PMID:
20637971
[PubMed - indexed for MEDLINE]
11.

Pharmacokinetics and pharmacodynamics of pegfilgrastim.

Yang BB, Kido A.

Clin Pharmacokinet. 2011 May;50(5):295-306. doi: 10.2165/11586040-000000000-00000. Review.

PMID:
21456630
[PubMed - indexed for MEDLINE]
12.

Pharmacokinetics, pharmacodynamics, and tolerability of a generic formulation of exenatide: a randomized, open-label, single- and multiple-dose study in healthy Chinese volunteers.

Shi S, Liu Y, Li Z, Wu J, Zhou X, Zeng F.

Arzneimittelforschung. 2012 Feb;62(2):75-82. doi: 10.1055/s-0031-1295484. Epub 2012 Feb 16.

PMID:
22344551
[PubMed - indexed for MEDLINE]
13.

Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.

Nohynek GJ, Plard JP, Wells MY, Zerial A, Roquet F.

Cancer Chemother Pharmacol. 1997;39(3):259-66.

PMID:
8996530
[PubMed - indexed for MEDLINE]
15.

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.

Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.

Clin Ther. 2006 Jan;28(1):55-72.

PMID:
16490580
[PubMed - indexed for MEDLINE]
16.

Tolerability and pharmacokinetics of a new P-glycoprotein inhibitor, HM30181, in healthy Korean male volunteers: single- and multiple-dose randomized, placebo-controlled studies.

Kim TE, Gu N, Yoon SH, Cho JY, Park KM, Shin SG, Jang IJ, Yu KS.

Clin Ther. 2012 Feb;34(2):482-94. doi: 10.1016/j.clinthera.2012.01.003. Epub 2012 Jan 28.

PMID:
22284902
[PubMed - indexed for MEDLINE]
17.

LY2189265, a long-acting glucagon-like peptide-1 analogue, showed a dose-dependent effect on insulin secretion in healthy subjects.

Barrington P, Chien JY, Tibaldi F, Showalter HD, Schneck K, Ellis B.

Diabetes Obes Metab. 2011 May;13(5):434-8. doi: 10.1111/j.1463-1326.2011.01365.x. Epub 2011 Jan 19.

PMID:
21251179
[PubMed - indexed for MEDLINE]
19.

Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.

Smith WB, Dowell JA, Pratt RD.

Clin Ther. 2007 Jul;29(7):1368-80.

PMID:
17825688
[PubMed - indexed for MEDLINE]
20.

Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children.

Stute N, Santana VM, Rodman JH, Schell MJ, Ihle JN, Evans WE.

Blood. 1992 Jun 1;79(11):2849-54.

PMID:
1375115
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk